Laramore G E, Bauer M, Griffin T W, Thomas F J, Hendrickson F R, Maor M H, Griffin B R, Saxton J P, Davis L W
Am J Clin Oncol. 1986 Jun;9(3):233-43. doi: 10.1097/00000421-198606000-00012.
From July 1979 through March 1984 the Radiation Therapy Oncology Group conducted a randomized study comparing fast neutron radiotherapy versus mixed beam (neutron/photon) radiotherapy versus conventional radiotherapy for patients with non-small cell carcinoma of the lung. Patients were either medically or technically inoperable. One hundred two evaluable patients were placed on the study. The radiation doses were approximately 60 Gy-equivalent on each arm. Patients were stratified according to size of primary, histology, Karnofsky performance status, and age distribution. Overall local response rates as measured by serial radiographs were the same on the three arms, and an actuarial analysis showed no significant differences in either median or long-term survival. However, for the subgroup of patients exhibiting a complete or partial tumor response at 6 months there was a suggestion of improved 3-year survival on the two experimental arms (mixed beam, 37%; neutrons, 25%; photons, 12%). The p value for the difference between the mixed beam and photon curves is 0.14 (two-sided test). The incidence of major complications was higher on the neutron and mixed beam arms. These complications included four cases of myelitis which are analyzed in detail. The results are placed in the context of other published work on the use of neutrons in the treatment of lung cancer.
1979年7月至1984年3月,放射治疗肿瘤学组开展了一项随机研究,比较快中子放射治疗、混合束(中子/光子)放射治疗与传统放射治疗对非小细胞肺癌患者的疗效。患者在医学或技术上均无法进行手术。102名可评估患者参与了该研究。每个治疗组的放射剂量约为60 Gy等效剂量。患者根据原发肿瘤大小、组织学类型、卡诺夫斯基功能状态和年龄分布进行分层。通过系列X光片测量的总体局部缓解率在三个治疗组中相同,精算分析显示中位生存期和长期生存率均无显著差异。然而,对于在6个月时出现肿瘤完全或部分缓解的患者亚组,两个试验组(混合束,37%;中子,25%;光子,12%)的3年生存率有提高的趋势。混合束组和光子组曲线差异的p值为0.14(双侧检验)。中子组和混合束组的主要并发症发生率较高。这些并发症包括4例脊髓炎,将对其进行详细分析。本文结果与其他已发表的关于中子用于治疗肺癌的研究进行了对比。